Original Research
Published on 23 Jan 2023
Strategies for five tumour markers in the screening and diagnosis of female breast cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1055855
- 23,874 views
- 25 citations
7,598 Publications
volumes
Original Research
Published on 23 Jan 2023
Epidemiology and survival of patients with central nervous system solitary fibrous tumors: A population-based analysis
Frontiers in Oncology
doi 10.3389/fonc.2022.977629
- 3,008 views
- 15 citations
Review
Published on 23 Jan 2023
Bacteria derived extracellular vesicles in the pathogenesis and treatment of gastrointestinal tumours
Frontiers in Oncology
doi 10.3389/fonc.2022.1103446
- 6,747 views
- 10 citations
Editorial
Published on 23 Jan 2023
Editorial: Brain and leptomeningeal metastases in lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1115126
- 1,748 views
- 1 citation
Case Report
Published on 20 Jan 2023
Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1079716
- 4,705 views
- 6 citations
Original Research
Published on 20 Jan 2023
HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell line
Frontiers in Oncology
doi 10.3389/fonc.2022.1082927
- 3,368 views
- 4 citations
Editorial
Published on 20 Jan 2023
Editorial: Imaging assessment of response to immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1116315
- 1,977 views
Original Research
Published on 20 Jan 2023
Breast cancer and dietary fat quality indices in Iranian women: A case–control study
Frontiers in Oncology
doi 10.3389/fonc.2022.993397
- 3,136 views
- 4 citations
Original Research
Published on 20 Jan 2023
Long-term outcomes of nasopharyngeal carcinoma treated with helical tomotherapy using simultaneous integrated boost technique: A 10-year result
Frontiers in Oncology
doi 10.3389/fonc.2022.1083440
- 2,623 views
- 5 citations
Case Report
Published on 20 Jan 2023
Case Report: Octreotide plus CVD chemotherapy for the treatment of multiple metastatic paragangliomas after double resection for functional bladder paraganglioma and urothelial papilloma
Frontiers in Oncology
doi 10.3389/fonc.2022.1072361
- 4,716 views
- 3 citations
Original Research
Published on 20 Jan 2023
Feasibility and acceptability of self-collection of Human Papillomavirus samples for primary cervical cancer screening on the Caribbean Coast of Nicaragua: A mixed-methods study
Frontiers in Oncology
doi 10.3389/fonc.2022.1020205
- 2,904 views
- 2 citations
Systematic Review
Published on 20 Jan 2023
Functional and postoperative outcomes after high-intensity interval training in lung cancer patients: A systematic review and meta-analysis
Frontiers in Oncology
doi 10.3389/fonc.2022.1029738
- 4,836 views
- 4 citations
Systematic Review
Published on 20 Jan 2023
The prognostic value of tumor-associated macrophages detected by immunostaining in diffuse large B cell lymphoma: A meta-analysis
Frontiers in Oncology
doi 10.3389/fonc.2022.1094400
- 3,891 views
- 14 citations
Original Research
Published on 20 Jan 2023
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1080729
- 3,480 views
- 7 citations
Review
Published on 20 Jan 2023
Current status of and progress in the treatment of malignant pleural effusion of lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.961440
- 27,847 views
- 20 citations
Original Research
Published on 20 Jan 2023
Transcriptomic profiling revealed FZD10 as a novel biomarker for nasopharyngeal carcinoma recurrence
Frontiers in Oncology
doi 10.3389/fonc.2022.1084713
- 2,789 views
- 4 citations
Original Research
Published on 20 Jan 2023
Downregulation of ITGβ3 in colon adenocarcinoma reveals poor prognosis by affecting genome stability, cell cycle, and the tumor immune microenvironment
Frontiers in Oncology
doi 10.3389/fonc.2022.1047648
- 3,137 views
- 2 citations
Original Research
Published on 19 Jan 2023
Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax
Frontiers in Oncology
doi 10.3389/fonc.2022.1068994
- 2,286 views
Case Report
Published on 19 Jan 2023
Exploration of chemotherapy-free regimen after multi-line chemotherapy-induced renal impairment in recurrent ovarian cancer: Case report and literature review
Frontiers in Oncology
doi 10.3389/fonc.2022.1031045
- 3,643 views
- 3 citations
Original Research
Published on 19 Jan 2023
Enhancer RNA-based modeling of adverse events and objective responses of cancer immunotherapy reveals associated key enhancers and target genes
Frontiers in Oncology
doi 10.3389/fonc.2022.1048127
- 3,617 views
- 1 citation
Review
Published on 19 Jan 2023
Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1062158
- 6,476 views
- 12 citations
Original Research
Published on 19 Jan 2023
Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population
Frontiers in Oncology
doi 10.3389/fonc.2022.1070761
- 9,702 views
- 18 citations
Original Research
Published on 19 Jan 2023
Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.978875
- 4,535 views
- 13 citations
Original Research
Published on 19 Jan 2023
Immunotherapy and tumor mutational burden in cancer patients with liver metastases: A meta and real word cohort analysis
Frontiers in Oncology
doi 10.3389/fonc.2022.994276
- 2,870 views
- 3 citations